Survival benefits of adjuvant chemotherapy after conversion surgery in patients with advanced pancreatic cancer
BackgroundOncologic outcomes of conversion surgery for advanced pancreatic cancer (PC) have scarcely been reported. Therefore, this study aimed to investigate the outcomes of conversion surgery with preoperative treatment of FOLFIRINOX or gemcitabine with nab-paclitaxel (GnP) for patients with advan...
Saved in:
Main Authors: | Yoon Suk Lee, Jang Won Lee, Hak Jun Kim, Jung Won Chun, Jong-Chan Lee, Dong Kee Jang, Jin-Hyeok Hwang, Young Ae Kim, Sang Myung Woo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1510016/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of systematic chemotherapy for metastatic pancreatic cancer: a retrospective study using Japanese clinical data
by: Akira Shinohara, et al.
Published: (2025-01-01) -
Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody (PADDLE)
by: Hidekazu Hirano, et al.
Published: (2025-02-01) -
A case report of successful treatment of advanced thymic squamous cell carcinoma with poor performance status using multimodal therapy
by: Xianhua Xu, et al.
Published: (2025-01-01) -
Metastatic pancreatic cancer now in remission: a case report and literature review
by: Charles W. Shi, et al.
Published: (2025-01-01) -
The real-world efficacy and toxicity of first-line paclitaxel and cisplatin with bevacizumab in platinum-naïve primary stage IVB cervical cancer
by: Junhwan Kim, et al.
Published: (2025-01-01)